BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7640642)

  • 1. Vascular actions of insulin in health and disease.
    Shoemaker JK; Bonen A
    Can J Appl Physiol; 1995 Jun; 20(2):127-54. PubMed ID: 7640642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function of Perivascular Nerves in Insulin Resistance-induced Hypertension].
    Takatori S
    Yakugaku Zasshi; 2017; 137(11):1367-1371. PubMed ID: 29093373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and hyperinsulinemia in hypertension.
    Weidmann P; Böhlen L; de Courten M
    J Hypertens Suppl; 1995 Aug; 13(2):S65-72. PubMed ID: 8576790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
    DeFronzo RA; Ferrannini E
    Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia.
    Lind L; Lithell H
    Am Heart J; 1993 May; 125(5 Pt 2):1494-7. PubMed ID: 8480620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders.
    Resnick LM
    Am J Med; 1992 Aug; 93(2A):11S-20S. PubMed ID: 1387762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance--not hyperinsulinemia--is pathogenic in essential hypertension.
    McCarty MF
    Med Hypotheses; 1994 Apr; 42(4):226-36. PubMed ID: 8072428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.
    Cleland SJ; Petrie JR; Ueda S; Elliott HL; Connell JM
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):175-84. PubMed ID: 9590566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasomotor abnormalities in insulin-resistant individuals.
    Quiñones MJ; Hernandez-Pampaloni M; Schelbert H; Bulnes-Enriquez I; Jimenez X; Hernandez G; De La Rosa R; Chon Y; Yang H; Nicholas SB; Modilevsky T; Yu K; Van Herle K; Castellani LW; Elashoff R; Hsueh WA
    Ann Intern Med; 2004 May; 140(9):700-8. PubMed ID: 15126253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
    Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
    J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of insulin resistance and hyperinsulinemia in coronary heart disease.
    Reaven GM
    Metabolism; 1992 May; 41(5 Suppl 1):16-9. PubMed ID: 1574008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes.
    Okon EB; Chung AW; Zhang H; Laher I; van Breemen C
    Can J Physiol Pharmacol; 2007 May; 85(5):562-7. PubMed ID: 17632592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular reactivity.
    Baron AD
    Am J Cardiol; 1999 Jul; 84(1A):25J-27J. PubMed ID: 10418855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web.
    DeFronzo RA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S1-16. PubMed ID: 1284137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanisms of insulin resistance].
    Holtz J
    Klin Wochenschr; 1992; 69 Suppl 29():52-62. PubMed ID: 1535403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperinsulinism. Causes and mechanisms].
    Del Prato S
    Presse Med; 1992 Sep; 21(28):1312-7. PubMed ID: 1332021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis.
    Standley PR; Bakir MH; Sowers JR
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):39-46. PubMed ID: 8503434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.